The medicines safety authority advised Pharmac it was “not desirable” for patients to switch brands of an anti-epilepsy drug now at the centre of a coronial inquest.
On Monday, Chief Coroner Deborah Marshall opened the second part of the inquiry into the deaths of six New Zealanders who died while taking Logem, a generic form of the anti-convulsant drug lamotrigine.
In 2019, a change in Pharmac funding resulted in 11,000 New Zealanders having their medication switched – a move which has seen seven deaths reported to the Centre for Adverse Reports Monitoring as possibly linked to the change.
On Tuesday, Chris James, the group manager for medicines regulator Medsafe, told the coroner the agency expressed concerns to Pharmac when the change was first proposed in 2018.
This bites personally because i know two people whose changed medicines caused enormous carnage in their lives.
THAT NO ONE AT PHARMAC THOUGHT CHANGING A MEDICINE SO VITAL TO THE WELL BEING OF PEOPLE WITH MENTAL HEALTH ISSUES WOULD BE A BIG DEAL HAS ME INCANDESCENT WITH RAGE!
…THIS is the real issues in NZ.
We think the masquerade of representative democracy puts us the people in control – it doesn’t! The Wellington Neoliberal Bureaucratic Elite stops transformative change and those running Pharmac have made a decision to buy a cheaper drug that has caused mayhem and damage in the lives of 11000 Kiwis.
How are they above accountability for the carnage they’ve caused in the lives of so many people?
Compensation to those impacted and the immediate sacking of any management involved in this decision alongside criminal prosecution for manslaughter is required.
Increasingly having independent opinion in a mainstream media environment which mostly echo one another has become more important than ever, so if you value having an independent voice – please donate here.
If you can’t contribute but want to help, please always feel free to share our blogs on social media